Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm
Epilepsy & Behavior · 2024
DOI: 10.1016/j.yebeh.2024.110123 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Debopam Samanta. Beteiligte Einrichtung: Division of Child Neurology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: dsamant…. Hauptthemen laut MEDLINE: Tuberous Sclerosis, Seizures, Anticonvulsants, Algorithms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 130 Literaturangaben.
Abstract (Originalsprache)
Tuberous sclerosis Complex (TSC) is a genetic disorder characterized by multisystem involvement, with epilepsy affecting 80-90% of patients, often beginning in infancy. Early-life seizures in TSC are associated with poor neurodevelopmental outcomes, underscoring the importance of timely and effective management. This review explores the evolving treatment landscape for TSC-associated seizures in young children, focusing on three recently approved or license-expanded therapies: vigabatrin, everolimus, and cannabidiol. The efficacy and safety profiles of these treatments are examined based on clinical trials and real-world evidence, with a focus on their use in treating seizures in young children. The preemptive use of vigabatrin in clinical studies has also been carefully reviewed. A treatment algorithm is proposed, emphasizing early diagnosis, prompt initiation of appropriate therapy, and a stepwise approach to managing both infantile spasms and focal seizures. The algorithm incorporates these newer therapies alongside traditional antiseizure medications and non-pharmacological approaches. Challenges in optimizing treatment strategies, minimizing side effects, and improving long-term outcomes are discussed. This review aims to guide clinicians in navigating the complex landscape of early-life seizures associated with TSC, ultimately striving for improved seizure control and better developmental outcomes in this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Child Neurology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: dsamanta@uams.edu.
Zitieren
APA
Samanta, D. (2024). Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.110123
Vancouver
Samanta D. Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2024.110123
BibTeX
@article{Samanta2024,
author = {Samanta, Debopam},
title = {Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm},
journal = {Epilepsy & Behavior},
year = {2024},
doi = {10.1016/j.yebeh.2024.110123}
}
EUVIMED